CDPPB attenuates risky behavior in a rodent model of PTSD/AUD comorbidity
Location
Culp Center Ballroom
Start Date
4-25-2023 9:00 AM
End Date
4-25-2023 11:00 AM
Poster Number
74
Faculty Sponsor’s Department
Biomedical Sciences
Name of Project's Faculty Sponsor
Justin Gass
Competition Type
Competitive
Type
Poster Presentation
Project's Category
Neuroscience
Abstract or Artist's Statement
Alcohol use disorder (AUD) is the leading cause of substance use disorders among Veterans and 55 to 75% of the population that are diagnosed with PTSD also receive a comorbid diagnosis of AUD. The co-diagnosis of PTSD/AUD is associated with neurocognitive changes such as increased impulsivity and risk-taking behavior, especially among individuals with combat-related trauma. Furthermore, increased neuroinflammation in subregions of the prefrontal cortex (PFC) are suggested to contribute to these neurocognitive changes. To better understand the cognitive deficits associated with co-occurring PTSD/AUD we incorporated a probabilistic discounting task (PDT) to model risk-based decision-making in male and female Wistar rats that were exposed to restraint stress (RS) and chronic intermittent ethanol exposure (CIE). Following RS and CIE, rats underwent lever press training through a series of different training phases, in which one lever delivered a small reward 100% of the time, and the other a large reward, delivered with descending probability each trial block. Pressing the large-reward lever during the final two trial blocks when it is disadvantageous to do so is considered “risky” behavior. A week prior to PDT, rats were treated prophylactically with CDPPB, a positive allosteric modulator of the metabotropic glutamate type 5 (mGlu5) receptor, to determine if the cognitive deficits caused by stress and alcohol exposure could be prevented. Additionally, to determine if our model mimicked the neuroinflammatory mechanism seen in the human condition and the therapeutic effects of CDPPB, we assessed TNF-⍺ protein expression in a subset of rats. Our results indicated that male rats exposed to RS and CIE had significantly greater responding during the 3rd, 4th, and 5th risk blocks compared to all other groups. However, the administration of CDPPB reversed this effect. Females exposed to RS and CIE only displayed increased risky behavior at the highest risk block and this was also blocked with the administration of CDPPB. We also determined that RS and CIE significantly increased TNF-⍺ levels in the IfL cortex compared to either RS or CIE alone and the prophylactic administration of CDPPB reduced TNF-⍺ protein expression to control animal levels. In the present study, we demonstrate that exposure to stress and chronic alcohol leads to significant neurocognitive deficits resulting in increased risky decision-making, but these deficits can be attenuated through modulation of the mGlu5 receptor prior to behavioral testing. Additionally, these deficits could be due to deleterious neuroinflammation in subregions of the PFC.
CDPPB attenuates risky behavior in a rodent model of PTSD/AUD comorbidity
Culp Center Ballroom
Alcohol use disorder (AUD) is the leading cause of substance use disorders among Veterans and 55 to 75% of the population that are diagnosed with PTSD also receive a comorbid diagnosis of AUD. The co-diagnosis of PTSD/AUD is associated with neurocognitive changes such as increased impulsivity and risk-taking behavior, especially among individuals with combat-related trauma. Furthermore, increased neuroinflammation in subregions of the prefrontal cortex (PFC) are suggested to contribute to these neurocognitive changes. To better understand the cognitive deficits associated with co-occurring PTSD/AUD we incorporated a probabilistic discounting task (PDT) to model risk-based decision-making in male and female Wistar rats that were exposed to restraint stress (RS) and chronic intermittent ethanol exposure (CIE). Following RS and CIE, rats underwent lever press training through a series of different training phases, in which one lever delivered a small reward 100% of the time, and the other a large reward, delivered with descending probability each trial block. Pressing the large-reward lever during the final two trial blocks when it is disadvantageous to do so is considered “risky” behavior. A week prior to PDT, rats were treated prophylactically with CDPPB, a positive allosteric modulator of the metabotropic glutamate type 5 (mGlu5) receptor, to determine if the cognitive deficits caused by stress and alcohol exposure could be prevented. Additionally, to determine if our model mimicked the neuroinflammatory mechanism seen in the human condition and the therapeutic effects of CDPPB, we assessed TNF-⍺ protein expression in a subset of rats. Our results indicated that male rats exposed to RS and CIE had significantly greater responding during the 3rd, 4th, and 5th risk blocks compared to all other groups. However, the administration of CDPPB reversed this effect. Females exposed to RS and CIE only displayed increased risky behavior at the highest risk block and this was also blocked with the administration of CDPPB. We also determined that RS and CIE significantly increased TNF-⍺ levels in the IfL cortex compared to either RS or CIE alone and the prophylactic administration of CDPPB reduced TNF-⍺ protein expression to control animal levels. In the present study, we demonstrate that exposure to stress and chronic alcohol leads to significant neurocognitive deficits resulting in increased risky decision-making, but these deficits can be attenuated through modulation of the mGlu5 receptor prior to behavioral testing. Additionally, these deficits could be due to deleterious neuroinflammation in subregions of the PFC.